Table 1.
Characteristics of NPDS exposures associated with intubation from 2000 to 2013
| Characteristic | Number | Percentage (95 % CI) |
|---|---|---|
| Single exposures to substances associated with intubation | Number of single exposures to substances associated with intubation | Percentage of total single exposures to substances associated with intubation |
| Total | 93,474 | |
| Age group | ||
| 0–5 years | 5517 | 5.9 % (5.8 to 6.1 %) |
| 6–12 years | 1059 | 1.1 % (1.1 to 1.2 %) |
| 13–19 years | 8961 | 9.6 % (9.4 to 9.8 %) |
| >19 years | 76,235 | 81.6 % (81.3 to 81.8 %) |
| Unknown | 1702 | 1.8 % (1.7 to 1.9 %) |
| Gender | ||
| Female | 44,415 | 47.5 % (47.2 to 47.8 %) |
| Five most common exposures | ||
| Atypical Antipsychotics | 6914 | 7.4 % (7.2 to 7.6 %) |
| Amitriptyline | 5627 | 6.0 % (5.9 to 6.2 %) |
| Benzodiazepines | 5036 | 5.4 % (5.2 to 5.5 %) |
| Ethanol | 2370 | 2.5 % (2.4 to 2.6 %) |
| Acetaminophen Combination products | 2344 | 2.5 % (2.4 to 2.6 %) |
| Multiple exposures to substances associated with intubation | Number of multiple exposures to substances associated with intubation | Percentagea of total multiple exposures to substances associated with intubation |
| Total | 228,507 | |
| Age group | ||
| 0–5 years | 6491 | 2.8 % (2.8 to 2.9 %) |
| 6–12 years | 1445 | 0.6 % (0.6 to 0.7 %) |
| 13–19 years | 18,815 | 8.2 % (8.2 to 8.3 %) |
| >19 years | 198,152 | 86.7 % (86.6 to 86.8 %) |
| Unknown | 3604 | 1.6 % (1.5 to 1.6 %) |
| Gender | ||
| Female | 118,700 | 51.9 % (51.7 to 52.2 %) |
| Five most common exposures | ||
| Benzodiazepines | 62,624 | 27.4 % (27.2 to 27.6 %) |
| Atypical Antipsychotics | 39,332 | 17.2 % (17.1 to 17.4 %) |
| Ethanol | 37,619 | 16.5 % (16.3 to 16.6 %) |
| Selective serotonin reuptake inhibitors | 22,277 | 9.7 % (9.6 to 9.9 %) |
| Other antidepressants | 17,434 | 7.6 % (7.5 to 7.7 %) |
aPercentage values were rounded to the nearest tenth of a percent